An update from FOXO Technologies ( (FOXO) ) is now available.
FOXO Technologies, a pioneer in epigenetic biomarker discovery, has had a transformative year in 2024, focusing on commercializing its technology and making strategic acquisitions to bolster growth in healthcare. The company’s recent acquisitions and patent for a machine learning model, which predicts health conditions using DNA data, position it for revenue expansion and innovation in AI-driven healthcare. FOXO is committed to meeting NYSE listing standards and enhancing shareholder value.
Learn more about FOXO stock on TipRanks’ Stock Analysis page.
